Kjell Erik Julius Håkansson

29PUBLICATIONS
151CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Economic models and forecastingCentral nervous systemAllergyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 25, 2026
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.

|Mar 05, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysis.

Kjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh

|Feb 20, 2026
Individual and Societal Economic Burden of Chronic Rhinosinusitis with or Without Nasal Polyps.

Kjell Erik Julius Håkansson, Steven Arild Wuyts Andersen, Anders Løkke

|Nov 27, 2025
Long-term efficacy but rare sustained remission: individual-level 5-year stability in anti-IL5/Rα biologic therapy response for severe asthma.

Kjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard

|Jul 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapy.

Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh

|Jul 15, 2025
Biologic Prescription Patterns and Biomarker Determinants of First-Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis.

Marianne Baastrup Soendergaard, Kjell Erik Julius Håkansson, Susanne Hansen

Pageof 5

Frequent Collaborators

20 joint publications

Charlotte Suppli Ulrik

7 joint publications

Ole Hilberg

7 joint publications

Vibeke Backer

7 joint publications

Marianne Baastrup Søndergaard